Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials

BACKGROUND: Pitolisant, a selective histamine 3 receptor antagonist/inverse agonist, is indicated for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The efficacy and safety of pitolisant have been demonstrated in randomized placebo-controlled trials. When evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Meskill, Gerard J., Davis, Craig W., Zarycranski, Donna, Doliba, Markiyan, Schwartz, Jean-Charles, Dayno, Jeffrey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732895/
https://www.ncbi.nlm.nih.gov/pubmed/34935103
http://dx.doi.org/10.1007/s40263-021-00886-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732895/
https://www.ncbi.nlm.nih.gov/pubmed/34935103
http://dx.doi.org/10.1007/s40263-021-00886-x

Ejemplares similares